KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Short term Debt (2017 - 2025)

Zoetis (ZTS) has disclosed Short term Debt for 12 consecutive years, with $1.4 billion as the latest value for Q2 2025.

  • On a quarterly basis, Short term Debt changed N/A to $1.4 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $1.4 billion, a N/A change, with the full-year FY2024 number at $1.4 billion, changed N/A from a year prior.
  • Short term Debt was $1.4 billion for Q2 2025 at Zoetis, roughly flat from $1.4 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.4 billion in Q1 2022 to a low of $2.0 million in Q4 2022.
  • A 5-year average of $615.7 million and a median of $312.0 million in 2021 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: skyrocketed 33650.0% in 2022, then plummeted 99.78% in 2023.
  • Zoetis' Short term Debt stood at $600.0 million in 2021, then plummeted by 99.67% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then soared by 67400.0% to $1.4 billion in 2024, then changed by 0.0% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Short term Debt are $1.4 billion (Q2 2025), $1.4 billion (Q1 2025), and $1.4 billion (Q4 2024).